Dong Haiping, Feng Jingyuan, Wu Shaoling, Liang Feng, Li Hua, Liang Xiaocheng, Liao Weixiang, Pan Yanshan, Tang Guidan, Li Donghai, Zhou Wei, Cao Zhizhong, Wang Weiyong, Hu Jinxing
The Second Tuberculosis Department, Guangzhou Chest Hospital, Guangzhou, Guangdong, China.
Medicine (Baltimore). 2025 Feb 14;104(7):e41409. doi: 10.1097/MD.0000000000041409.
Although paracoccidioidomycosis is one of the most prevalent endemic mycoses in Latin American countries, where at least 10 million people are infected, the prevalence of paracoccidioidomycosis in China remains unknown because no related case has been reported, and its diagnosis is extremely challenging for local clinicians because of the complexity of disease progression and lack of specific evidence.
Here, we report the first case of PCM in a male patient with a long-term latent infection in China.
The results of special staining, immunohistochemistry, lymph node biopsy pathology, and metagenomic second-generation sequencing indicated that the patient was infected with Paracoccidioides brasiliensis.
In this case, the patient was administered voriconazole 200 mg twice daily.
After continuous treatment for 6 months, the patient's symptoms improved significantly, and the medication was discontinued. The outpatient follow-up revealed no discomfort.
This case is of great value for the early diagnosis, treatment, and prevention of the spread of this emerging infectious disease in China.
尽管副球孢子菌病是拉丁美洲国家最普遍的地方性真菌病之一,那里至少有1000万人感染,但中国副球孢子菌病的患病率仍然未知,因为尚无相关病例报告,并且由于疾病进展的复杂性和缺乏特异性证据,其诊断对当地临床医生极具挑战性。
在此,我们报告中国首例长期潜伏感染的男性副球孢子菌病患者。
特殊染色、免疫组织化学、淋巴结活检病理及宏基因组二代测序结果表明,该患者感染了巴西副球孢子菌。
该病例中,患者接受伏立康唑治疗,每日两次,每次200毫克。
持续治疗6个月后,患者症状显著改善,药物停用。门诊随访未发现不适。
该病例对于中国这种新发传染病的早期诊断、治疗及预防传播具有重要价值。